APP and Alzheimer disease: Studies indicate that a loss of NEU1 function results in the accumulation of hypersialylated APP, leading to increased amyloidogenic processing and the release of amyloid-beta peptides pivotal in the pathogenesis of AD [107,165,167,168,171].